Postdoctoral Fellow
Alberta Diabetes Institute, University of Alberta, Canada
Dr Alice Carr is a Postdoctoral Fellow at the Alberta Diabetes Institute (Canada), having completed her PhD at the University of Exeter (UK) in 2022. As an interdisciplinary researcher and data scientist, her research spans the field of type 1 diabetes (T1D), integrating foundational and clinical data to drive advances that will improve the lives of people with T1D.
Her research is deeply rooted within the University of Alberta’s Clinical Islet Transplant Program (CITP), where she has the privilege to work on unique datasets to inform clinical decision making and support individuals considering islet transplantation or future stem-cell derived islet therapies. She has expertise in the analysis of continuous glucose monitoring (CGM) data, using it to understand how residual beta cell function influences glycemic control and contributes to the daily burden of living with T1D. She is also interested in CGMs potential to monitor high-risk individuals for earlier identification and monitoring of progression to Stage 3 T1D. She is a key member of several international collaborative initiatives focused on T1D prevention and new-onset trials, including the Type 1 Diabetes Consortium hosted by the Critical Path Institute (Tucson, AZ), and plays a leading role in metabolic modelling to inform the design of future T1D intervention trials.
She is committed to fostering collaboration, accessibility, and transparency of data analytics in diabetes research and maintains a repository of open-sourced tools to simplify analysis in various contexts. Passionate about making data science approachable, she also mentors students and researchers, helping them build their confidence in coding, develop reproducible analysis pipelines, and learn how to think critically and creatively about their data.
Driven by her lived experience of T1D, her goal is to advance our understanding of the disease and help find ways to improve the lives of those who live with it every day.
Disclosure information not submitted.
Expanding Opportunities for Pharmacometrics in the Era of Digital Health
Sunday, October 19, 2025
2:00 PM - 3:30 PM MDT
Sunday, October 19, 2025
2:00 PM - 2:20 PM MDT
Panel - Expanding Opportunities for Pharmacometrics in the Era of Digital Health
Sunday, October 19, 2025
3:00 PM - 3:30 PM MDT